Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
CSPC Pharmaceutical Group ( (HK:1093) ) has issued an update.
CSPC Pharmaceutical Group Limited announced the on-market purchase of 3,000,000 shares as part of its restricted share award scheme. This move, involving a total consideration of approximately HK$26,590,000, represents about 0.026% of the existing total number of shares in issue. The purchase is intended to benefit selected participants and reflects the company’s ongoing commitment to its share award scheme, potentially impacting its market positioning and stakeholder interests.
The most recent analyst rating on (HK:1093) stock is a Hold with a HK$10.00 price target. To see the full list of analyst forecasts on CSPC Pharmaceutical Group stock, see the HK:1093 Stock Forecast page.
More about CSPC Pharmaceutical Group
CSPC Pharmaceutical Group Limited is a Hong Kong-based company operating in the pharmaceutical industry. The company focuses on the development, manufacturing, and sale of pharmaceutical products, catering to a wide range of healthcare needs.
Average Trading Volume: 169,595,138
Technical Sentiment Signal: Buy
Current Market Cap: HK$106.6B
See more insights into 1093 stock on TipRanks’ Stock Analysis page.